Abstract
This protocol outlines a systematic review and meta-analysis designed to compare the short-term safety and efficacy of robotic-assisted pancreatoduodenectomy (RPD) versus laparoscopic pancreatoduodenectomy (LPD). By aggregating data from randomized controlled trials (RCTs) and non-randomized clinical trials, this study aims to provide a high-level evidence base for surgical decision-making in complex pancreatic procedures.
Introduction
The pancreatoduodenectomy, commonly known as the Whipple procedure, is a cornerstone of gastrointestinal surgery for treating various pancreatic and periampullary diseases. Historically performed as an open procedure, the surgical landscape has transitioned toward minimally invasive surgery (MIS) to improve patient recovery and reduce postoperative morbidity. Within the MIS domain, two primary modalities have emerged: Laparoscopic (LPD) and Robotic (RPD).
LPD is well-established but presents significant technical challenges, including a steep learning curve and limited instrument maneuverability. In contrast, RPD offers enhanced 3D visualization and a greater range of motion through articulated instruments, potentially overcoming some of the limitations of laparoscopy. However, RPD is associated with higher equipment costs and specialized training requirements. Currently, there is no definitive consensus on which approach offers superior short-term clinical outcomes. This protocol establishes the framework for a comprehensive meta-analysis to address this gap.
Methodology
Study Design and Search Strategy
This study follows the PRISMA guidelines for systematic reviews. A comprehensive search of major medical databases, including PubMed, Embase, and the Cochrane Library, was conducted for studies published through December 23, 2021. The search strategy focused on identifying both RCTs and observational studies comparing RPD and LPD in adult patients.
Inclusion and Exclusion Criteria
Studies were included if they involved human subjects undergoing pancreatoduodenectomy for any pancreatic disease (benign or malignant) and provided a direct comparison between robotic and laparoscopic techniques. Only English-language articles were considered.
Statistical Analysis
Data synthesis and meta-analysis will be performed using RevMan 5.4. The researchers will utilize Cochran’s Q and $I^2$ tests to evaluate statistical heterogeneity. A fixed-effect model will be applied if $I^2 < 50\%$; otherwise, a random-effects model will be used, and potential sources of variation will be investigated through subgroup analysis. To ensure the robustness of the findings, a "leave-one-out" sensitivity analysis will be performed by sequentially removing individual studies to observe their impact on the overall effect size.
Quality Assessment
The methodological quality of included RCTs will be assessed using the Cochrane Risk Bias Tool. For non-randomized observational studies, the Newcastle-Ottawa Scale (NOS) will be employed to evaluate selection, comparability, and outcome reporting.
Evaluation Metrics
Primary Outcomes
The primary focus of this review is the immediate postoperative safety and efficacy, measured by:
- Rate of conversion to open surgery.
- Length of hospital stay (LOS).
- Overall postoperative complication rates.
Secondary Outcomes
Secondary metrics include intraoperative and specific postoperative data:
- Operative time and estimated blood loss.
- Reoperation rates and 30-day mortality.
- Incidence of Postoperative Pancreatic Fistula (POPF) and Delayed Gastric Emptying (DGE).
- Surgical site infections (SSI) and deep vein thrombosis (DVT).
Discussion and Significance
The focus on short-term metrics is clinically significant because the most critical complications of pancreatic surgery typically manifest within the immediate postoperative period. By mapping granular outcomes like POPF and DGE—the "gold standard" metrics for pancreatic resection quality—this study will provide a detailed safety profile for both RPD and LPD.
Furthermore, the planned subgroup analyses based on patient age and pathology (benign vs. malignant) will help determine if specific patient populations derive greater benefit from the robotic platform. This level of nuance is essential for personalized surgical planning and resource allocation in high-volume surgical centers.
Limitations and Future Directions
Several limitations are inherent to this protocol. The restriction to English-language publications may introduce language bias, potentially omitting significant data from non-English speaking regions with high surgical volumes. Additionally, the inclusion of non-randomized studies introduces a risk of selection bias, as surgeons may select the robotic or laparoscopic platform based on patient-specific factors not captured in the data.
Future research should expand upon these findings by investigating long-term oncological outcomes, such as overall survival and recurrence rates, as well as the long-term cost-effectiveness of robotic technology compared to conventional laparoscopy.
Conclusion
This systematic review and meta-analysis protocol provides a rigorous methodology for comparing RPD and LPD. By synthesizing global clinical data, the resulting study will offer valuable insights into the short-term efficacy of these two minimally invasive approaches, ultimately guiding surgeons and healthcare systems in optimizing pancreatic care.
Summary updated